Active

Droia Oncology Ventures

Investor type

VC

Founded

2011

AUM

$675 M

Location

Zaventem, Flemish Brabant, Belgium

Investment Ticket

$1-5 m

Investment Stage

Seed Series A

Region of investment

North America Europe Asia
Investor profile last updated: 09 May, 2026

Profile

Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients. We are specialists, investing exclusively in therapeutics for oncology and genetic disease.

Our focus and our in-house team of drug development experts and biotech professionals allow us to accelerate our companies’ progress by actively supporting them from company creation through clinical proof of concept. We are hands-on investors and entrepreneurs, fully dedicated to making an impact and saving patient lives.

Industry

Biotechnology Healthcare Services Medical Devices Pharmaceuticals SaaS Blockchain/Crypto AI MedTech Life Sciences VR/AR HealthTech Marketing and Advertising Media and Entertainment Software

Droia Oncology Ventures Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Droia Oncology Ventures Fund II
Venture Capital (VC)
Biotechnology
Healthcare Services
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$265 M
May 2021
Fund II
Venture Capital (VC)
Healthcare Services
Marketing and Advertising
Media and Entertainment
SaaS
Software
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$62 M
April 2026

Contacts

Name
Title
Email
avatar
Luc Dochez Co-Founder and Executive Chairman
Co-Founder and Executive Chairman
l•••@•••
avatar
Janwillem Naesens Managing Partner
Managing Partner
j•••@•••
Upgrade to see contacts
avatar
PUaNB3TjtSGMdK80 PUaNB3TjtSGMdK80
PUaNB3TjtSGMdK80
avatar
PUaNB3TjtSGMdK80 PUaNB3TjtSGMdK80
PUaNB3TjtSGMdK80
avatar
PUaNB3TjtSGMdK80 PUaNB3TjtSGMdK80
PUaNB3TjtSGMdK80
Investment-team contacts for Droia Oncology Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Droia Oncology Ventures

Droia Oncology Ventures is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $1-5 m.
Droia Oncology Ventures is located in Zaventem, Flemish Brabant, Belgium.
Droia Oncology Ventures was founded in 2011.
Droia Oncology Ventures invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, Pharmaceuticals, SaaS, Blockchain/Crypto, AI, MedTech, Life Sciences, VR/AR, HealthTech, Marketing and Advertising, Media and Entertainment, Software.
Droia Oncology Ventures invests in companies and startups in North America, Europe, Asia.
Droia Oncology Ventures invests in companies and startups at Seed, Series A.
Droia Oncology Ventures usually invests $1-5 m on average.
Droia Oncology Ventures has around $675m assets under management.
Droia Oncology Ventures last fund was created/launched in 2026-04-23
Droia Oncology Ventures can be reached through its website droiaventures.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Droia Oncology Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Droia Oncology Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 09 May, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.